Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-04, Stock:PFE, The news for the past five days is as follows:
2019-01-28: NEWS1: Pfizer Stock Is at Do-or-Die Spot Ahead of Earnings.NEWS2: Pfizer Stock Is at Do-or-Die Spot Ahead of Earnings.NEWS3: The worst-performing Dow stock this year is about to report earnings. Here's what to expect.NEWS4: Pre-Market Earnings Report for January 29, 2019 :  PFE, VZ, MMM, LMT, DHR, BIIB, AGN, HCA, GLW, PCAR, ROK, NUE.NEWS5: Pre-Market Earnings Report for January 29, 2019 :  PFE, VZ, MMM, LMT, DHR, BIIB, AGN, HCA, GLW, PCAR, ROK, NUE.NEWS6: Pfizer is Oversold.NEWS7: Pfizer is Oversold.NEWS8: 5 Dow Jones Stocks Under Pressure.NEWS9: Pfizer Stock Is at Do-or-Die Spot Ahead of Earnings.NEWS10: Q4 Earnings Outlook For Pfizer.NEWS11: Earnings Preview: Apple, AMD, Verizon, Other Giants to Report Crucial Q4.NEWS12: Drug/Biotech Stock Earnings on Jan 29: PFE, AMGN, BIIB & AGN.NEWS13: Drug/Biotech Stock Earnings on Jan 29: PFE, AMGN, BIIB & AGN.NEWS14: 3 Big Stock Charts for Monday: Pfizer, MGM Resorts and Incyte.NEWS15: 3 Big Stock Charts for Monday: Pfizer, MGM Resorts and Incyte.NEWS16: PFE Makes Notable Cross Below Critical Moving Average.NEWS17: PFE Makes Notable Cross Below Critical Moving Average.NEWS18: Stocks Move Significantly Lower On Disappointing Earnings News - U.S. Commentary.NEWS19: Stocks Move Significantly Lower On Disappointing Earnings News - U.S. Commentary.NEWS20: Week in Review: U.S. Markets Quiet During Short Week as Government Shutdown Temporarily Ended.NEWS21: Week in Review: U.S. Markets Quiet During Short Week as Government Shutdown Temporarily Ended.NEWS22: Drug/Biotech Stock Earnings on Jan 29: PFE, AMGN, BIIB & AGN.NEWS23: Clovis' Rubraca Gets Nod as Maintenance Therapy in Europe.NEWS24: Clovis' Rubraca Gets Nod as Maintenance Therapy in Europe.NEWS25: Health Care Sector Update for 01/28/2019: TRVN, ARAY, ABBV, JNJ, PFE, ABT, MRK, AMGN.NEWS26: Health Care Sector Update for 01/28/2019: TRVN, ARAY, ABBV, JNJ, PFE, ABT, MRK, AMGN.NEWS27: 3 Big Stock Charts for Monday: Pfizer, MGM Resorts and Incyte.NEWS28: Clovis' Rubraca Gets Nod as Maintenance Therapy in Europe.NEWS29: Pfizer Pivots to Cancer Drugs for Growth.
2019-01-29: NEWS1: What Happened in the Stock Market Today.NEWS2: What Happened in the Stock Market Today.NEWS3: Here's when an earnings miss isn't really a miss: Jim Cramer.NEWS4: Pfizer, 3M Earnings Propel Dow to a Win.NEWS5: Pfizer, 3M Earnings Propel Dow to a Win.NEWS6: Asian Markets Mostly Lower Ahead Of Fed Decision, Trade Talks.NEWS7: Asian Markets Mostly Lower Ahead Of Fed Decision, Trade Talks.NEWS8: US Market Indexes Close Flat on Tuesday.NEWS9: What Happened in the Stock Market Today.NEWS10: Close Update: Dow Scratches Out Small Gain as Other Major Indexes Slump.NEWS11: Close Update: Dow Scratches Out Small Gain as Other Major Indexes Slump.NEWS12: After Hours Most Active for Jan 29, 2019 :  ABEV, FCX, PFE, ITUB, PG, TVPT.NEWS13: After Hours Most Active for Jan 29, 2019 :  ABEV, FCX, PFE, ITUB, PG, TVPT.NEWS14: 3 Stocks Move Tuesday.NEWS15: Market Close Report: NASDAQ Composite index closes at 7,028.29 down -57.40 points.NEWS16: Market Close Report: NASDAQ Composite index closes at 7,028.29 down -57.40 points.NEWS17: Pfizer, Allergan Stocks Diverge On Earnings Beat, Weak Sales Outlook.NEWS18: Japanese Market Drifts Lower.NEWS19: Japanese Market Drifts Lower.NEWS20: Continued Selling Pressure Predicted For Thai Shares.NEWS21: Continued Selling Pressure Predicted For Thai Shares.NEWS22: Pfizer Tops Q4 Earnings But Guides for Weaker 2019 as Lyrica Exclusivity Ends.NEWS23: Dow Closes Modestly Higher Ahead of Apple Earnings.NEWS24: Indonesia Stock Market May Test Support At 6,400 Points.NEWS25: Indonesia Stock Market May Test Support At 6,400 Points.NEWS26: The 5 Best Dow Jones Stocks to Buy Now.NEWS27: Australian Market Modestly Higher.NEWS28: Australian Market Modestly Higher.NEWS29: Losses May Accelerate For Hong Kong Shares.NEWS30: Losses May Accelerate For Hong Kong Shares.NEWS31: Dow Gives Up Gains as Stocks Falter Ahead of Apple Earnings.NEWS32: China Bourse Expected To Open Under Pressure.NEWS33: China Bourse Expected To Open Under Pressure.NEWS34: Pfizer Q4 Earnings Update: 4 Key Things You Need to Know.NEWS35: More Pain Predicted For Taiwan Stock Market.NEWS36: More Pain Predicted For Taiwan Stock Market.NEWS37: Continued Consolidation Called For Singapore Stock Market.NEWS38: Continued Consolidation Called For Singapore Stock Market.NEWS39: Dow Trades Higher and Nasdaq Stumbles Ahead of Apple Earnings.NEWS40: Apple Earnings Preview & Latest Results from Verizon, 3M, and Pfizer.NEWS41: Pfizer swings to loss due to restructuring, asset writedowns.NEWS42: Pfizer swings to loss due to restructuring, asset writedowns.NEWS43: Malaysia Bourse May Extend Losing Streak.NEWS44: Malaysia Bourse May Extend Losing Streak.NEWS45: Pfizer quarterly profit in line, touts pipeline of future products.NEWS46: South Korea Shares May See Renewed Selling Pressure.NEWS47: South Korea Shares May See Renewed Selling Pressure.NEWS48: Major Averages Close Mixed Following Lackluster Session - U.S. Commentary.NEWS49: Major Averages Close Mixed Following Lackluster Session - U.S. Commentary.NEWS50: Stocks making moves midday: PulteGroup, 3M, Harley-Davidson & more.NEWS51: Apple To Report Fiscal Q1 Earnings.NEWS52: Pfizer’s ‘Promising Outlook’ Still Shines for Analysts After Earnings Report.NEWS53: Dow Gets Lift From 3M as Wall Street Awaits Earnings From Apple.NEWS54: The Apple (AAPL) of Investors' Eye.NEWS55: Dow Leads Despite Mixed Earnings Results; Apple Earnings On Deck.NEWS56: Pfizer&apos;s Subpar Outlook Embodies Pharma&apos;s Plight.NEWS57: Pfizer (PFE) Q4 Earnings Beat, 2019 View Tepid, Stock Dips.NEWS58: Stocks Mixed Ahead Of Trade Talks, Fed, Apple; Cat Leads Dow Jones.NEWS59: Dow earnings reporters&apos; stocks would boost Dow&apos;s price by 11 points.NEWS60: Dow earnings reporters' stocks would boost Dow's price by 11 points.NEWS61: 4 Things Exact Sciences Investors Should Know About 23andMe&apos;s New Cancer Test.NEWS62: US STOCKS-Wall St set to open higher after latest batch of earnings.NEWS63: Pfizer (PFE) Q4 Earnings & Sales Beat, 2019 View Disappoints.NEWS64: Pfizer&apos;s Outlook Disappoints as Drugmaker Focuses on Pipeline.NEWS65: Pfizer’s Fiscal 2019 Guidance Disappoints Investors.NEWS66: Stocks making the biggest moves premarket: 3M, Pfizer, Verizon, Xerox & more.NEWS67: Stocks making the biggest moves premarket: 3M, Pfizer, Verizon, Xerox & more.NEWS68: [$$] Pfizer sees strong dollar weighing on results in 2019.NEWS69: US STOCKS-Wall St futures flat, eyes on China impact.NEWS70: Pfizer Earnings Top, But Dow Jones Drug Giant Guides Low; Allergan Earnings Beat.NEWS71: Pfizer shares slide 2% premarket after it swings to loss, guidance lags consensus.NEWS72: Pfizer full-year revenue forecast misses estimates.NEWS73: Pfizer's earnings outlook disappoints after Viagra loses patent protection and Lyrica faces same fate.NEWS74: Pfizer's earnings beat forecast, but shares fall as company's outlook disappoints.NEWS75: PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2018 RESULTS.NEWS76: Pfizer and Lilly Announce Top-Line Results From Second Phase 3 Study of Tanezumab in Osteoarthritis Pain.NEWS77: Major Averages Turning In Mixed Performance In Morning Trading - U.S. Commentary.NEWS78: Major Averages Turning In Mixed Performance In Morning Trading - U.S. Commentary.NEWS79: Stocks May Show Initial Move To The Upside - U.S. Commentary.NEWS80: Stocks May Show Initial Move To The Upside - U.S. Commentary.NEWS81: Futures Point To Moderately Positive Opening For Wall Street.NEWS82: Futures Point To Moderately Positive Opening For Wall Street.NEWS83: Pfizer Q4 Results Beat View; But FY19 Outlook Disappoints.NEWS84: Pfizer Q4 Results Beat View; But FY19 Outlook Disappoints.NEWS85: Pfizer Shares Slump 2% After Cutting Full-Year Revenue Outlook.NEWS86: Pfizer, Lilly Announce Results From Phase 3 Study Of Tanezumab In OA Pain.NEWS87: Pfizer, Lilly Announce Results From Phase 3 Study Of Tanezumab In OA Pain.
2019-01-30: NEWS1: Edited Transcript of PFE earnings conference call or presentation 29-Jan-19 3:00pm GMT.NEWS2: Pfizer: Flat Operational EPS Performance in Fiscal 2019?.NEWS3: Pfizer Expects Flat Operational Revenue in Fiscal 2019.NEWS4: What Should Apple Do With Its Cash?.NEWS5: Pfizer: Analysts’ Recommendations after Its Q4 Results.NEWS6: Pfizer's Near-Term Correction Could Be Over.NEWS7: Company News For Jan 30, 2019.NEWS8: Company News For Jan 30, 2019.NEWS9: Pfizer Beats Expectations but Reaction Is Muted.NEWS10: Amgen (AMGN) Q4 Earnings Beat Estimates, 2019 Guidance Tepid.NEWS11: Amgen (AMGN) Q4 Earnings Beat Estimates, 2019 Guidance Tepid.NEWS12: Lilly/Pfizer's Osteoarthritis Pain Drug Succeeds in 2nd Study.NEWS13: Lilly/Pfizer's Osteoarthritis Pain Drug Succeeds in 2nd Study.NEWS14: 3 Big Pharmas Expecting a Softer 2019.NEWS15: 3 Big Pharmas Expecting a Softer 2019.NEWS16: Health Care Sector Update for 01/30/2019: CODX, ANTM, ACIU, JNJ, PFE, MRK, ABT, AMGN.NEWS17: Health Care Sector Update for 01/30/2019: CODX, ANTM, ACIU, JNJ, PFE, MRK, ABT, AMGN.NEWS18: Company News For Jan 30, 2019.NEWS19: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for January 31, 2019.NEWS20: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for January 31, 2019.NEWS21: Lilly/Pfizer's Osteoarthritis Pain Drug Succeeds in 2nd Study.NEWS22: A Cure for Cancer Next Year? The Stock Market Says Don't Believe the Hype.NEWS23: A Cure for Cancer Next Year? The Stock Market Says Don't Believe the Hype.NEWS24: Amgen (AMGN) Q4 Earnings Beat Estimates, 2019 Guidance Tepid.NEWS25: 3 Big Pharmas Expecting a Softer 2019.NEWS26: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS27: A Cure for Cancer Next Year? The Stock Market Says Don&apos;t Believe the Hype.NEWS28: New Jersey’s College Savings Plan Bought Up AT&T, Amazon, and GM Stock.NEWS29: Pfizer Well-Positioned, Undervalued.NEWS30: Pfizer (PFE) Q4 2018 Earnings Conference Call Transcript.NEWS31: Pfizer (PFE) Q4 2018 Earnings Conference Call Transcript.NEWS32: Better Buy: Johnson & Johnson vs. Pfizer.NEWS33: Better Buy: Johnson & Johnson vs. Pfizer.NEWS34: Pfizer (PFE) Q4 2018 Earnings Conference Call Transcript.NEWS35: Better Buy: Johnson & Johnson vs. Pfizer.NEWS36: [$$] Pfizer Results Hurt by Pricing Challenges.NEWS37: The 5 Best Dow Jones Stocks to Buy Now.NEWS38: The 5 Best Dow Jones Stocks to Buy Now.
2019-01-31: NEWS1: Nasdaq Closes Out Best Month Since 2011.NEWS2: Nasdaq Closes Out Best Month Since 2011.NEWS3: Merck's Pneumococcal Vaccine Gets Breakthrough Therapy Status.NEWS4: Merck's Pneumococcal Vaccine Gets Breakthrough Therapy Status.NEWS5: Merck's Pneumococcal Vaccine Gets Breakthrough Therapy Status.NEWS6: Dow Movers: DWDP, PFE.NEWS7: Dow Movers: DWDP, PFE.NEWS8: Pfizer Stock’s ‘Dark Period’ Might Finally Be Over.NEWS9: Pfizer: Ibrance and Xtandi Are Key Oncology Assets.NEWS10: Pfizer Rises 3%.NEWS11: Health Care Sector Update for 01/31/2019: SCYX, PULM, BAX, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 01/31/2019: SCYX, PULM, BAX, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Oncology Portfolio: Pfizer’s Key Growth Driver in Fiscal 2018.NEWS14: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS15: Pfizer’s Expenses Are Expected to Rise in Fiscal 2019.NEWS16: Why are deep-pocketed biotechs cutting hundreds of jobs?.NEWS17: What Should Apple Do With Its Cash?.NEWS18: What Should Apple Do With Its Cash?.NEWS19: Jim Cramer: When Is a Miss Not a Miss?.
2019-02-01: NEWS1: Top Analyst Reports for Boeing, Thermo Fisher & Anthem.NEWS2: Top Analyst Reports for Boeing, Thermo Fisher & Anthem.NEWS3: Top Analyst Reports for Boeing, Thermo Fisher & Anthem.NEWS4: Dow 30 Stock Roundup: MCD, BA, 3M, MSFT, PFE, V Earnings Impress.NEWS5: Pharma Catches Another Case Of M&A Fever.NEWS6: Health Care Sector Update for 02/01/2019: TTNP, CTIC, OPK, JNJ, PFE, MRK, ABT, AMGN.NEWS7: Health Care Sector Update for 02/01/2019: TTNP, CTIC, OPK, JNJ, PFE, MRK, ABT, AMGN.NEWS8: Pfizer Receives Positive CHMP Opinion for Vizimpro® (dacomitinib) for the First-line Treatment of Adult Patients with Locally Advanced Or Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations.NEWS9: Dow 30 Stock Roundup: MCD, BA, 3M, MSFT, PFE, V Earnings Impress.NEWS10: Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY.NEWS11: Watch These Healthcare Stocks in First Week of February.NEWS12: Xeljanz: Pfizer’s Key Immunology Asset in Fiscal 2019.NEWS13: Pfizer Gets Positive CHMP Opinion For Vizimpro 45 Mg.NEWS14: Pfizer Gets Positive CHMP Opinion For Vizimpro 45 Mg.

Answer: Decrease